- Home
- GOSS vs KNOP Comparison
GOSS vs KNOP Comparison
Compare GOSS & KNOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GOSS | KNOP |
|---|---|---|
| Founded | 2015 | 2013 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 796.2M | 346.6M |
| IPO Year | 2019 | 2013 |
Fundamental Metrics
Financial Performance| Metric | GOSS | KNOP |
|---|---|---|
| Price | $3.19 | $10.61 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 1 |
| Target Price | ★ $8.60 | N/A |
| AVG Volume (30 Days) | ★ 4.2M | 122.9K |
| Earning Date | 11-05-2025 | 12-04-2025 |
| Dividend Yield | N/A | ★ 0.99% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.17 |
| Revenue | $44,051,000.00 | ★ $352,712,000.00 |
| Revenue This Year | N/A | $14.84 |
| Revenue Next Year | $6.41 | $1.98 |
| P/E Ratio | ★ N/A | $8.97 |
| Revenue Growth | N/A | ★ 17.65 |
| 52 Week Low | $0.76 | $5.28 |
| 52 Week High | $3.87 | $10.99 |
Technical Indicators
Market Signals| Indicator | GOSS | KNOP |
|---|---|---|
| Relative Strength Index (RSI) | 46.76 | 59.00 |
| Support Level | $3.21 | $10.37 |
| Resistance Level | $3.87 | $10.60 |
| Average True Range (ATR) | 0.29 | 0.25 |
| MACD | -0.06 | -0.04 |
| Stochastic Oscillator | 3.42 | 64.14 |
Price Performance
Historical ComparisonAbout GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About KNOP KNOT Offshore Partners LP
KNOT Offshore Partners LP owns, operates, and shuttles tankers under long-term charters in the North Sea and Brazil. The company provides crude oil loading, transportation, and storage services under time charters and bareboat charters. The Partnership is formed for acquiring ownership interests in over four shuttle tankers owned by Knutsen NYK Offshore Tankers AS (KNOT). It operates through the shuttle tanker market segment.